William J. Placzek

A survey of the anti-apoptotic Bcl-2 subfamily expression in cancer types provides a platform to predict the efficacy of Bcl-2 antagonists in cancer therapy

William J. Placzek, Jun Wei, Shinichi Kitada et al. · Cell Death and Disease · 2010 · 287 citations · Full text

Cancer Therapy, Immunology, Cell Death +17

The E3 Ubiquitin Ligase Siah2 Contributes to Castration-Resistant Prostate Cancer by Regulation of Androgen Receptor Transcriptional Activity

Jianfei Qi, Manisha Tripathi, Rajeev Mishra et al. · Cancer Cell · 2013 · 159 citations · Full text

Transcriptional Regulation, Urology, Medicine +5

BI-97C1, an Optically Pure Apogossypol Derivative as Pan-Active Inhibitor of Antiapoptotic B-Cell Lymphoma/Leukemia-2 (Bcl-2) Family Proteins

Jun Wei, John L. Stebbins, Shinichi Kitada et al. · Journal of Medicinal Chemistry · 2010 · 115 citations · Full text

Immunology, Cell Death, Pharmacotherapy +17

Novel Targeted System To Deliver Chemotherapeutic Drugs to EphA2-Expressing Cancer Cells

Si Wang, William J. Placzek, John L. Stebbins et al. · Journal of Medicinal Chemistry · 2012 · 91 citations · Full text

Cancer Biology, Tumor Biology, Anti-cancer Agent +16

Serum galactose-deficient-IgA1 and IgG autoantibodies correlate in patients with IgA nephropathy

William J. Placzek, Hiroyuki Yanagawa, Yuko Makita et al. · PLoS ONE · 2018 · 75 citations · Full text

Glomerular Disease, Renal Pathology, Immunology +22